Twist Bioscience Corporation
TWST · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $377 | $313 | $245 | $204 |
| % Growth | 20.3% | 27.7% | 20.4% | – |
| Cost of Goods Sold | $186 | $180 | $155 | $119 |
| Gross Profit | $191 | $133 | $90 | $84 |
| % Margin | 50.7% | 42.6% | 36.6% | 41.4% |
| R&D Expenses | $80 | $91 | $107 | $120 |
| G&A Expenses | $240 | $0 | $187 | $0 |
| SG&A Expenses | $247 | $218 | $190 | $213 |
| Sales & Mktg Exp. | $7 | $0 | $3 | $0 |
| Other Operating Expenses | $0 | $45 | $10 | -$14 |
| Operating Expenses | $327 | $354 | $307 | $319 |
| Operating Income | -$136 | -$221 | -$217 | -$235 |
| % Margin | -36.2% | -70.6% | -88.6% | -115.3% |
| Other Income/Exp. Net | $59 | $13 | $14 | $7 |
| Pre-Tax Income | -$77 | -$208 | -$203 | -$228 |
| Tax Expense | $1 | $1 | $1 | -$10 |
| Net Income | -$78 | -$209 | -$205 | -$218 |
| % Margin | -20.6% | -66.7% | -83.5% | -107% |
| EPS | -1.3 | -3.6 | -3.6 | -4.04 |
| % Growth | 63.9% | 0% | 10.9% | – |
| EPS Diluted | -1.3 | -3.6 | -3.6 | -4.04 |
| Weighted Avg Shares Out | 60 | 58 | 57 | 54 |
| Weighted Avg Shares Out Dil | 60 | 58 | 57 | 54 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $15 | $14 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $25 | $31 | $29 | $17 |
| EBITDA | -$52 | -$177 | -$174 | -$212 |
| % Margin | -13.8% | -56.5% | -71.1% | -104% |